The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo

Molecular and Cellular Neuroscience

Volumn 30, Issue 4, 2005, Pages 552-558

  Lebeurrier, Nathalie ^a   Liot, Géraldine ^a,b   Lopez Atalaya, José P ^a   Orset, Cyrille ^a   Fernandez Monreal, Monica ^a,c   Sonderegger, Peter ^d   Ali, Carine ^a   Vivien, Denis ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b BURNHAM INSTITUTE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSERPIN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ACTIVITY; DRUG MECHANISM; EMBRYO; EXCITOTOXICITY; MALE; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RODENT;

ANIMALS; APOPTOSIS; BRAIN; BRAIN ISCHEMIA; CALCIUM SIGNALING; CELLS, CULTURED; CEREBRAL CORTEX; CEREBROVASCULAR ACCIDENT; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; MALE; MICE; N-METHYLASPARTATE; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RECEPTORS, N-METHYL-D-ASPARTATE; SERPINS;

ANIMALIA; RODENTIA;

EID: 28344454373     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2005.09.005     Document Type: Article

References (32)

1. K. Benchenane, J.P. Lopez-Atalaya, M. Fernandez-Monreal, O. Touzani, and D. Vivien Equivocal roles of tissue-type plasminogen activator in stroke-induced injury Trends Neurosci. 27 2004 155 160
2. K. Benchenane, V. Berezowski, C. Ali, M. Fernandez-Monreal, J.P. Lopez-Atalaya, J. Brillault, J. Chuquet, A. Nouvelot, E.T. MacKenzie, G. Bu, R. Cecchelli, O. Touzani, and D. Vivien Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis Circulation 111 2005 2241 2249
3. A. Buisson, O. Nicole, F. Docagne, H. Sartelet, E.T. Mackenzie, and D. Vivien Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1 FASEB J. 12 1998 1683 1691
4. Z.L. Chen, and S. Strickland Neuronal death in the hippocampus is promoted by plasmin-catalized degradation of laminin Cell 91 1997 917 925
5. P. Cinelli, R. Madani, N. Tsuzuki, P. Vallet, M. Arras, C.N. Zhao, T. Osterwalder, T. Rulicke, and P. Sonderegger Neuroserpin, a neuroprotective factor in focal ischemic stroke Mol. Cell. Neurosci. 18 2001 443 457
6. F. Docagne, O. Nicole, H.H. Marti, E.T. MacKenzie, A. Buisson, and D. Vivien Transforming growth factor-β1 as a regulator of the serpins/t-PA axis in cerebral ischemia FASEB J. 13 1999 1315 1324
7. F. Docagne, O. Nicole, C. Gabriel, M. Fernandez-Monreal, S. Lesne, C. Ali, L. Plawinski, P. Carmeliet, E.T. MacKenzie, A. Buisson, and D. Vivien Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis Mol. Cell. Neurosci. 21 2002 634 644
8. M. Fernandez-Monreal, J.P. Lopez-Atalaya, K. Benchenane, M. Cacquevel, F. Dulin, J.P. Le Caer, J. Rossier, A.C. Jarrige, E.T. Mackenzie, N. Colloc'h, C. Ali, and D. Vivien Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-d-aspartate receptor signaling J. Biol. Chem. 279 2004 50850 50856
9. C. Gabriel, C. Ali, S. Lesne, M. Fernandez-Monreal, F. Docagne, L. Plawinski, E.T. MacKenzie, A. Buisson, and D. Vivien Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity FASEB J. 17 2003 277 279
10. G.A. Hastings, T.A. Coleman, C.C. Haudenschild, S. Stefansson, E.P. Smith, R. Barthlow, S. Cherry, M. Sandkvist, and D.A. Lawrence Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival J. Biol. Chem. 272 1997 33062 33067
11. J.A. Indyk, Z.L. Chen, S.E. Tsirka, and S. Strickland Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury Neuroscience 116 2003 359 371
12. J.Y. Koh, and D.W. Choi Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay J. Neurosci. Methods 20 1987 83 90
13. S.R. Krueger, G.P. Ghisu, P. Cinelli, T.P. Gschwend, T. Osterwalder, D.P. Wolfer, and P. Sonderegger Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse J. Neurosci. 17 1997 8984 8996
14. N. Lebeurrier, D. Vivien, and C. Ali The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management? Expert Opin. Ther. Targets 8 2004 309 320
15. G. Liot, C. Gabriel, M. Cacquevel, C. Ali, E.T. MacKenzie, A. Buisson, and D. Vivien Neurotrophin-3-induced PI-3 kinase/Akt signalling rescues cortical neurons from apoptosis Exp. Neurol. 187 2004 38 46
16. D.P. Martin, R.E. Schmidt, P.S. DiStefano, O.H. Lowry, J.G. Carter, and E.M. Johnson Jr. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation J. Cell Biol. 106 1988 829 844
17. N. Nagai, M. De Mol, H.R. Lijnen, P. Carmeliet, and D. Collen Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice Circulation 99 1999 2440 2444
18. N. Nagai, T. Urano, A. Endo, H. Takahashi, Y. Takada, and A. Takada Neuronal degenaration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection Neurosci. Res. 33 1999 147 154
19. NINDS (The National Institute of Neurological Disorders and Stroke) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group N. Engl. J. Med. 333 1995 1581 1587
20. O. Nicole, F. Docagne, C. Ali, I. Margaill, P. Carmeliet, E.T. MacKenzie, D. Vivien, and A. Buisson The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling Nat. Med. 7 2001 59 64
21. O. Nicole, C. Ali, F. Docagne, L. Plawinski, E.T. MacKenzie, D. Vivien, and A. Buisson Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway J. Neurosci. 21 2001 3024 3033
22. T. Osterwalder, J. Contartese, E.T. Stoeckli, T.B. Kuhn, and P. Sonderegger Neuroserpin, an axonally secreted serine protease inhibitor EMBO J. 15 1996 2944 2953
23. T. Osterwalder, P. Cinelli, A. Baici, A. Penella, S.R. Krueger, S.P. Schrimpf, M. Meins, and P. Sonderegger Theaxonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin J. Biol. Chem. 273 1998 2312 2321
24. D.C. Rijken, and D.V. Sakharov Basic principles in thrombolysis: regulatory role of plasminogen Thromb. Res. 103 2001 S41 S49
25. K. Rose, M.P. Goldberg, and D.W. Choi Cytotoxicity in murine cortical cell culture C.A. Tyson J.M. Frazier In Vitro Biological Methods 1993 Academic Press San Diego, CA 46 60
26. S.E. Tsirka, A. Gualandris, D.G. Amaral, and S. Strickland Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator Nature 377 1995 340 344
27. J.D. Vassalli, A.P. Sappina, and D. Berlin The plasminogen activator/plasmin system J. Clin. Invest. 88 1991 1067 1072
28. D. Vivien, and A. Buisson Serine protease inhibitors: novel therapeutic targets for stroke? J. Cereb. Blood Flow Metab. 20 2000 755 764
29. Y.F. Wang, S.E. Tsirka, S. Strickland, P.E. Stieg, S.G. Soriano, and S.A. Lipton Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice Nat. Med. 4 1998 228 231
30. M. Yepes, M. Sandkvist, M.K. Wong, T.A. Coleman, E. Smith, S.L. Cohan, and D.A. Lawrence Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis Blood 96 2000 569 576
31. Z. Zhang, L. Zhang, M. Yepes, Q. Jiang, Q. Li, P. Arniego, T.A. Coleman, D.A. Lawrence, and M. Chopp Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke Circulation 106 2002 740 745
32. J.A. Zivin, P.D. Lyden, U. DeGirolami, A. Kochlar, V. Mazarella, C.C. Hemenway, and P. Johnston Tissue plasminogen activator. Reduction of neurological damage after experimental embolic stroke Arch. Neurol. 45 1988 387 391